top of page
ABOUT
TEAM
PORTFOLIO
NEWS
CONTACT
More
Use tab to navigate through the menu items.
bor-ē-ǎl-
ǐ
s
bringing together the elements to
build visionary healthcare companies
Learn More
RECENT NEWS
COMPASS' TOVECIMIG (CTX-009) MEETS
PRIMARY ENDPOINT IN PHASE 2/3 STUDY
APRIL 1, 2025
ANKYRA THERAPEUTICS EXPANDS
COLLABORATION WITH J&J
JANUARY 10, 2025
See More News
bottom of page
